EG24605A - Antihistaminic spiro compounds - Google Patents

Antihistaminic spiro compounds

Info

Publication number
EG24605A
EG24605A EG162699A EG162699A EG24605A EG 24605 A EG24605 A EG 24605A EG 162699 A EG162699 A EG 162699A EG 162699 A EG162699 A EG 162699A EG 24605 A EG24605 A EG 24605A
Authority
EG
Egypt
Prior art keywords
spiro compounds
antihistaminic
antihistaminic spiro
compounds
spiro
Prior art date
Application number
EG162699A
Other languages
English (en)
Inventor
Frans E Janssens
Joseph E Leenaerts
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of EG24605A publication Critical patent/EG24605A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG162699A 1998-12-19 1999-12-18 Antihistaminic spiro compounds EG24605A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98204347 1998-12-19

Publications (1)

Publication Number Publication Date
EG24605A true EG24605A (en) 2010-01-10

Family

ID=8234498

Family Applications (1)

Application Number Title Priority Date Filing Date
EG162699A EG24605A (en) 1998-12-19 1999-12-18 Antihistaminic spiro compounds

Country Status (37)

Country Link
US (2) US7148214B1 (sk)
EP (1) EP1144411B1 (sk)
JP (1) JP4601175B2 (sk)
KR (1) KR100598725B1 (sk)
CN (1) CN1258533C (sk)
AR (1) AR021888A1 (sk)
AT (1) ATE294178T1 (sk)
AU (1) AU764820C (sk)
BG (1) BG65133B1 (sk)
BR (1) BR9916371A (sk)
CA (1) CA2355939C (sk)
CO (1) CO5140116A1 (sk)
CZ (1) CZ301953B6 (sk)
DE (1) DE69925036T2 (sk)
DK (1) DK1144411T3 (sk)
EA (1) EA004500B1 (sk)
EE (1) EE04917B1 (sk)
EG (1) EG24605A (sk)
ES (1) ES2242443T3 (sk)
HK (1) HK1043128B (sk)
HR (1) HRP20010453B1 (sk)
HU (1) HU229406B1 (sk)
ID (1) ID29268A (sk)
IL (1) IL143767A0 (sk)
MY (1) MY129663A (sk)
NO (1) NO318891B1 (sk)
NZ (1) NZ512870A (sk)
PL (1) PL196262B1 (sk)
PT (1) PT1144411E (sk)
SA (1) SA00210113B1 (sk)
SI (1) SI1144411T1 (sk)
SK (1) SK286158B6 (sk)
TR (1) TR200101711T2 (sk)
TW (1) TWI250981B (sk)
UA (1) UA74537C2 (sk)
WO (1) WO2000037470A1 (sk)
ZA (1) ZA200104977B (sk)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ531679A (en) * 2001-10-15 2005-02-25 Janssen Pharmaceutica Nv Novel substituted 4-phenyl-4-[1H-imidazol-2-YL]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
IL161347A0 (en) * 2001-10-15 2004-09-27 Janssen Pharmaceutica Nv Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
EP1765052A4 (en) * 2004-05-11 2012-06-20 George E Alliss TRIMMER
DE602005014124D1 (de) * 2004-09-07 2009-06-04 Banyu Pharma Co Ltd Carbamoylsubstituiertes spiro-derivat
EP2722333A1 (en) 2008-04-29 2014-04-23 Novartis AG Spiro-indole derivatives for the treatment of parasitic diseases.
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
SG11201602445SA (en) 2013-10-04 2016-04-28 Infinity Pharmaceuticals Inc Heterocyclic compounds and uses thereof
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2015143012A1 (en) 2014-03-19 2015-09-24 Infinity Pharmaceuticals, Inc. Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
MX2017002610A (es) 2014-08-29 2017-10-11 Tes Pharma S R L INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA.
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
CN108349985A (zh) 2015-09-14 2018-07-31 无限药品股份有限公司 异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
WO2017088080A1 (es) 2015-11-25 2017-06-01 Natural Response S.A. Método para la obtención de saponinas a partir de plantas
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
KR20240052355A (ko) 2022-10-14 2024-04-23 지이 일렉트리컬 엔지니어링 컴퍼니., 리미티드. 여과 장치용 커버
KR20240052354A (ko) 2022-10-14 2024-04-23 지이 일렉트리컬 엔지니어링 컴퍼니., 리미티드. 여과 장치
CN117624052B (zh) * 2024-01-26 2024-04-12 四川益能康生环保科技有限公司 一种用于捕集二氧化碳的离子液体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464380A (en) 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
CA2093797C (en) * 1990-10-10 1998-09-22 Richard J. Friary Substituted imidazobenzazepines and imidazopyridoazepines
IL101851A (en) 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
US5106844A (en) * 1991-09-10 1992-04-21 Sterling Drug Inc. Imidazo[2,2-b][3]benzazepine and pyrimido[2,1-b][3]benzazepine antiarrhythmic agents
TW382017B (en) 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives

Also Published As

Publication number Publication date
MY129663A (en) 2007-04-30
PL348295A1 (en) 2002-05-20
JP4601175B2 (ja) 2010-12-22
ATE294178T1 (de) 2005-05-15
HUP0104779A3 (en) 2003-12-29
AU3041200A (en) 2000-07-12
EA200100681A1 (ru) 2001-12-24
CN1331694A (zh) 2002-01-16
ID29268A (id) 2001-08-16
CO5140116A1 (es) 2002-03-22
SK286158B6 (sk) 2008-04-07
NO20012710L (no) 2001-06-01
SA00210113B1 (ar) 2006-09-13
TR200101711T2 (tr) 2001-12-21
CA2355939C (en) 2010-12-14
EP1144411A1 (en) 2001-10-17
ZA200104977B (en) 2002-06-18
NZ512870A (en) 2003-11-28
DK1144411T3 (da) 2005-09-19
HK1043128B (zh) 2007-01-19
WO2000037470A1 (en) 2000-06-29
NO20012710D0 (no) 2001-06-01
KR100598725B1 (ko) 2006-07-11
AR021888A1 (es) 2002-08-07
BR9916371A (pt) 2001-09-18
JP2002533344A (ja) 2002-10-08
ES2242443T3 (es) 2005-11-01
UA74537C2 (uk) 2006-01-16
WO2000037470A8 (en) 2000-08-24
HRP20010453B1 (en) 2010-07-31
EP1144411B1 (en) 2005-04-27
EE200100328A (et) 2002-08-15
NO318891B1 (no) 2005-05-18
EE04917B1 (et) 2007-10-15
EA004500B1 (ru) 2004-04-29
HU229406B1 (en) 2013-12-30
HK1043128A1 (en) 2002-09-06
SK8142001A3 (en) 2002-04-04
BG65133B1 (bg) 2007-03-30
CZ20012069A3 (cs) 2002-02-13
SI1144411T1 (en) 2005-10-31
HUP0104779A2 (hu) 2002-04-29
AU764820C (en) 2004-11-18
US20050026901A1 (en) 2005-02-03
CA2355939A1 (en) 2000-06-29
KR20010075655A (ko) 2001-08-09
CZ301953B6 (cs) 2010-08-11
DE69925036D1 (de) 2005-06-02
PL196262B1 (pl) 2007-12-31
US7148214B1 (en) 2006-12-12
DE69925036T2 (de) 2006-01-26
PT1144411E (pt) 2005-09-30
BG105546A (en) 2001-12-29
TWI250981B (en) 2006-03-11
IL143767A0 (en) 2002-04-21
HRP20010453A2 (en) 2002-06-30
US7087595B2 (en) 2006-08-08
AU764820B2 (en) 2003-08-28
CN1258533C (zh) 2006-06-07

Similar Documents

Publication Publication Date Title
HRP20020102B1 (en) Novel spiro compounds
HUP0203375A3 (en) Substituted oxoazaheterocyclyl compounds
GB9801392D0 (en) Novel compounds
EG24605A (en) Antihistaminic spiro compounds
GB9817029D0 (en) Novel compounds
PL336307A1 (en) Crambescidin compounds
ZA200200734B (en) Spiro compounds.
GB9801630D0 (en) Novel compounds
GB9802664D0 (en) Novel compounds
GB9801634D0 (en) Novel compounds
GB9801633D0 (en) Novel compounds
GB9801632D0 (en) Novel compounds
GB9801643D0 (en) Novel compounds
GB9802640D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9802656D0 (en) Novel compounds
GB9803952D0 (en) Novel compounds
GB9802801D0 (en) Novel compounds
GB9802798D0 (en) Novel compounds
GB9802795D0 (en) Novel compounds
GB9802698D0 (en) Novel compounds
GB9802665D0 (en) Novel compounds
GB9801635D0 (en) Novel compounds
GB9802661D0 (en) Novel compounds
GB9802659D0 (en) Novel compounds